GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:190002612 | Liver | Cirrhotic | positive regulation of substrate adhesion-dependent cell spreading | 23/4634 | 41/18723 | 1.75e-05 | 2.38e-04 | 23 |
GO:00301951 | Liver | Cirrhotic | negative regulation of blood coagulation | 26/4634 | 49/18723 | 1.93e-05 | 2.57e-04 | 26 |
GO:19020416 | Liver | Cirrhotic | regulation of extrinsic apoptotic signaling pathway via death domain receptors | 26/4634 | 49/18723 | 1.93e-05 | 2.57e-04 | 26 |
GO:19000471 | Liver | Cirrhotic | negative regulation of hemostasis | 26/4634 | 50/18723 | 3.07e-05 | 3.84e-04 | 26 |
GO:00508191 | Liver | Cirrhotic | negative regulation of coagulation | 27/4634 | 53/18723 | 3.51e-05 | 4.29e-04 | 27 |
GO:000716011 | Liver | Cirrhotic | cell-matrix adhesion | 85/4634 | 233/18723 | 4.06e-05 | 4.83e-04 | 85 |
GO:000759611 | Liver | Cirrhotic | blood coagulation | 79/4634 | 217/18723 | 8.06e-05 | 8.81e-04 | 79 |
GO:00341097 | Liver | Cirrhotic | homotypic cell-cell adhesion | 39/4634 | 90/18723 | 8.57e-05 | 9.25e-04 | 39 |
GO:000759911 | Liver | Cirrhotic | hemostasis | 80/4634 | 222/18723 | 1.08e-04 | 1.10e-03 | 80 |
GO:001077012 | Liver | Cirrhotic | positive regulation of cell morphogenesis involved in differentiation | 35/4634 | 79/18723 | 1.13e-04 | 1.14e-03 | 35 |
GO:005081711 | Liver | Cirrhotic | coagulation | 79/4634 | 222/18723 | 1.90e-04 | 1.76e-03 | 79 |
GO:00457857 | Liver | Cirrhotic | positive regulation of cell adhesion | 141/4634 | 437/18723 | 2.05e-04 | 1.89e-03 | 141 |
GO:00723761 | Liver | Cirrhotic | protein activation cascade | 9/4634 | 12/18723 | 3.59e-04 | 3.03e-03 | 9 |
GO:00107205 | Liver | Cirrhotic | positive regulation of cell development | 99/4634 | 298/18723 | 5.71e-04 | 4.46e-03 | 99 |
GO:19020424 | Liver | Cirrhotic | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors | 16/4634 | 31/18723 | 1.15e-03 | 7.83e-03 | 16 |
GO:00705553 | Liver | Cirrhotic | response to interleukin-1 | 52/4634 | 143/18723 | 1.27e-03 | 8.54e-03 | 52 |
GO:00610451 | Liver | Cirrhotic | negative regulation of wound healing | 31/4634 | 78/18723 | 2.43e-03 | 1.46e-02 | 31 |
GO:005087812 | Liver | Cirrhotic | regulation of body fluid levels | 118/4634 | 379/18723 | 2.65e-03 | 1.55e-02 | 118 |
GO:19040191 | Liver | Cirrhotic | epithelial cell apoptotic process | 44/4634 | 121/18723 | 2.86e-03 | 1.65e-02 | 44 |
GO:00723781 | Liver | Cirrhotic | blood coagulation, fibrin clot formation | 7/4634 | 10/18723 | 3.29e-03 | 1.83e-02 | 7 |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0517114 | Liver | NAFLD | Coronavirus disease - COVID-19 | 111/1043 | 232/8465 | 1.01e-41 | 3.32e-39 | 2.67e-39 | 111 |
hsa04610 | Liver | NAFLD | Complement and coagulation cascades | 35/1043 | 86/8465 | 2.48e-11 | 2.04e-09 | 1.64e-09 | 35 |
hsa0517115 | Liver | NAFLD | Coronavirus disease - COVID-19 | 111/1043 | 232/8465 | 1.01e-41 | 3.32e-39 | 2.67e-39 | 111 |
hsa046101 | Liver | NAFLD | Complement and coagulation cascades | 35/1043 | 86/8465 | 2.48e-11 | 2.04e-09 | 1.64e-09 | 35 |
hsa0517122 | Liver | Cirrhotic | Coronavirus disease - COVID-19 | 136/2530 | 232/8465 | 3.28e-20 | 1.82e-18 | 1.12e-18 | 136 |
hsa046102 | Liver | Cirrhotic | Complement and coagulation cascades | 48/2530 | 86/8465 | 4.41e-07 | 5.44e-06 | 3.35e-06 | 48 |
hsa0517132 | Liver | Cirrhotic | Coronavirus disease - COVID-19 | 136/2530 | 232/8465 | 3.28e-20 | 1.82e-18 | 1.12e-18 | 136 |
hsa046103 | Liver | Cirrhotic | Complement and coagulation cascades | 48/2530 | 86/8465 | 4.41e-07 | 5.44e-06 | 3.35e-06 | 48 |
hsa0517142 | Liver | HCC | Coronavirus disease - COVID-19 | 167/4020 | 232/8465 | 1.50e-14 | 4.19e-13 | 2.33e-13 | 167 |
hsa046104 | Liver | HCC | Complement and coagulation cascades | 57/4020 | 86/8465 | 3.19e-04 | 1.45e-03 | 8.04e-04 | 57 |
hsa046112 | Liver | HCC | Platelet activation | 71/4020 | 124/8465 | 1.77e-02 | 4.15e-02 | 2.31e-02 | 71 |
hsa0517152 | Liver | HCC | Coronavirus disease - COVID-19 | 167/4020 | 232/8465 | 1.50e-14 | 4.19e-13 | 2.33e-13 | 167 |
hsa046105 | Liver | HCC | Complement and coagulation cascades | 57/4020 | 86/8465 | 3.19e-04 | 1.45e-03 | 8.04e-04 | 57 |
hsa0461111 | Liver | HCC | Platelet activation | 71/4020 | 124/8465 | 1.77e-02 | 4.15e-02 | 2.31e-02 | 71 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
FGB | SNV | Missense_Mutation | | c.979N>A | p.Asp327Asn | p.D327N | P02675 | protein_coding | deleterious(0) | possibly_damaging(0.753) | TCGA-AO-A1KS-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD |
FGB | SNV | Missense_Mutation | | c.1309T>G | p.Cys437Gly | p.C437G | P02675 | protein_coding | deleterious(0) | probably_damaging(0.981) | TCGA-AR-A1AW-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | docetaxel | SD |
FGB | insertion | Nonsense_Mutation | novel | c.59_60insTTATAGTTTGTGAGATTTTCAGATCTTGTCCTCTTAATTGTAATCCTGTATT | p.Leu20PhefsTer5 | p.L20Ffs*5 | P02675 | protein_coding | | | TCGA-AR-A0U0-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
FGB | insertion | Frame_Shift_Ins | novel | c.1365_1366insTGTGTTTGTT | p.Met456CysfsTer11 | p.M456Cfs*11 | P02675 | protein_coding | | | TCGA-AR-A0U0-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
FGB | insertion | Frame_Shift_Ins | novel | c.1366_1367insCTTTATAC | p.Met456ThrfsTer13 | p.M456Tfs*13 | P02675 | protein_coding | | | TCGA-AR-A0U0-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
FGB | insertion | Frame_Shift_Ins | novel | c.790_791insG | p.Lys264ArgfsTer4 | p.K264Rfs*4 | P02675 | protein_coding | | | TCGA-BH-A0HX-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adrimycin | SD |
FGB | insertion | Nonsense_Mutation | novel | c.792_793insTTGGTGACTAAATACAAAGTAATTATGTCATAAAC | p.Pro265LeufsTer11 | p.P265Lfs*11 | P02675 | protein_coding | | | TCGA-BH-A0HX-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adrimycin | SD |
FGB | SNV | Missense_Mutation | novel | c.1210N>C | p.Phe404Leu | p.F404L | P02675 | protein_coding | tolerated(0.77) | benign(0.018) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FGB | SNV | Missense_Mutation | | c.1086N>T | p.Gln362His | p.Q362H | P02675 | protein_coding | tolerated(0.16) | possibly_damaging(0.516) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR |
FGB | SNV | Missense_Mutation | | c.1330N>A | p.Gly444Ser | p.G444S | P02675 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AZ-4315-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
2244 | FGB | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, FIBRINOGEN, DRUGGABLE GENOME | inhibitor | CHEMBL1201505 | FIBRINOLYSIN, HUMAN | |
2244 | FGB | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, FIBRINOGEN, DRUGGABLE GENOME | | RECOMBINANT FACTOR IX FC FUSION PROTEIN | | |
2244 | FGB | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, FIBRINOGEN, DRUGGABLE GENOME | | HAEMATOXYLIN | HAEMATOXYLIN | |
2244 | FGB | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, FIBRINOGEN, DRUGGABLE GENOME | | eptifibatide | EPTIFIBATIDE | 20938371 |
2244 | FGB | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, FIBRINOGEN, DRUGGABLE GENOME | | ALFIMEPRASE | ALFIMEPRASE | |
2244 | FGB | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, FIBRINOGEN, DRUGGABLE GENOME | | abciximab | ABCIXIMAB | 20938371 |
2244 | FGB | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, FIBRINOGEN, DRUGGABLE GENOME | | tirofiban | TIROFIBAN | 20938371 |
2244 | FGB | CELL SURFACE, EXTERNAL SIDE OF PLASMA MEMBRANE, FIBRINOGEN, DRUGGABLE GENOME | | METHYLTHIONINIUM CHLORIDE | METHYLTHIONINIUM CHLORIDE | |